Literature DB >> 18377872

Quercetin augments TRAIL-induced apoptotic death: involvement of the ERK signal transduction pathway.

Young-Ho Kim1, Dae-Hee Lee, Jae-Hoon Jeong, Zong Sheng Guo, Yong J Lee.   

Abstract

Combined treatment with quercetin and TRAIL induced cytotoxicity and enhanced annexin V staining and poly (ADP-ribose) polymerase (PARP) cleavage in human prostate cancer cell lines DU-145 and PC-3. These indicators of apoptosis resulted from the activation of caspase-8, -9, and -3. Although the expression levels of FLIPs, cIAP1, cIAP2, and the Bcl-2 family were not changed in quercetin-treated cells, significant downregulation of survivin occurred. Knockdown survivin by siRNA significantly increased TRAIL-induced apoptosis. We hypothesized that quercetin-induced activation of MAPK (ERK, p38, JNK) is responsible for downregulation of survivin gene expression. To test this hypothesis, we selectively inhibited MAPK during treatment with quercetin. Our data demonstrated that inhibitor of ERK (PD98059), but not p38 MAPK (SB203580) or JNK (SP600125), significantly maintained the intracellular level of survivin during treatment with quercetin. Interestingly, PD98059 also prevented quercetin-induced deacetylation of histone H3. Data from survivin promoter activity assay suggest that the Sp1 transcription factor binds to the survivin promoter region and quercetin inhibits its binding activity through deacetylation of histone H3. Quercetin-induced activation of the ERK-MSK1 signal transduction pathway may be responsible for deacetylation of histone H3. Taken together, our findings suggest that quercetin enhances TRAIL induced apoptosis by inhibition of survivin expression, through ERK-MSK1-mediated deacetylation of H3.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18377872      PMCID: PMC2430102          DOI: 10.1016/j.bcp.2008.02.016

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  37 in total

1.  Transcriptional analysis of human survivin gene expression.

Authors:  F Li; D C Altieri
Journal:  Biochem J       Date:  1999-12-01       Impact factor: 3.857

2.  MSK2 and MSK1 mediate the mitogen- and stress-induced phosphorylation of histone H3 and HMG-14.

Authors:  Ana Soloaga; Stuart Thomson; Giselle R Wiggin; Navita Rampersaud; Mark H Dyson; Catherine A Hazzalin; Louis C Mahadevan; J Simon C Arthur
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

Review 3.  Validating survivin as a cancer therapeutic target.

Authors:  Dario C Altieri
Journal:  Nat Rev Cancer       Date:  2003-01       Impact factor: 60.716

Review 4.  The fundamental role of epigenetic events in cancer.

Authors:  Peter A Jones; Stephen B Baylin
Journal:  Nat Rev Genet       Date:  2002-06       Impact factor: 53.242

Review 5.  Targeting death receptors in cancer with Apo2L/TRAIL.

Authors:  Sean K Kelley; Avi Ashkenazi
Journal:  Curr Opin Pharmacol       Date:  2004-08       Impact factor: 5.547

6.  Sensitization for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by the chemopreventive agent resveratrol.

Authors:  Simone Fulda; Klaus-Michael Debatin
Journal:  Cancer Res       Date:  2004-01-01       Impact factor: 12.701

7.  Quercetin-induced growth inhibition and cell death in nasopharyngeal carcinoma cells are associated with increase in Bad and hypophosphorylated retinoblastoma expressions.

Authors:  Chye Sun Ong; Evelyn Tran; T T Tuyen Nguyen; Choon Kiat Ong; Siew Kuen Lee; Jia Jing Lee; Chee Pang Ng; Caine Leong; Hung Huynh
Journal:  Oncol Rep       Date:  2004-03       Impact factor: 3.906

8.  Direct binding of Fas-associated death domain (FADD) to the tumor necrosis factor-related apoptosis-inducing ligand receptor DR5 is regulated by the death effector domain of FADD.

Authors:  Lance R Thomas; Adrianna Henson; John C Reed; Freddie R Salsbury; Andrew Thorburn
Journal:  J Biol Chem       Date:  2004-06-01       Impact factor: 5.157

9.  Upregulation of survivin in G2/M cells and inhibition of caspase 9 activity enhances resistance in staurosporine-induced apoptosis.

Authors:  Anmol Chandele; Vandna Prasad; Jayashree C Jagtap; Ravi Shukla; Padma R Shastry
Journal:  Neoplasia       Date:  2004 Jan-Feb       Impact factor: 5.715

10.  Perturbation of microtubule polymerization by quercetin through tubulin binding: a novel mechanism of its antiproliferative activity.

Authors:  Kamlesh Gupta; Dulal Panda
Journal:  Biochemistry       Date:  2002-10-29       Impact factor: 3.162

View more
  46 in total

1.  Quercetin-mediated Mcl-1 and survivin downregulation restores TRAIL-induced apoptosis in non-Hodgkin's lymphoma B cells.

Authors:  Guillaume Jacquemin; Virginie Granci; Anne Sophie Gallouet; Najoua Lalaoui; Aymeric Morlé; Elisabetta Iessi; Alexandre Morizot; Carmen Garrido; Thierry Guillaudeux; Olivier Micheau
Journal:  Haematologica       Date:  2011-09-20       Impact factor: 9.941

Review 2.  Combining naturally occurring polyphenols with TNF-related apoptosis-inducing ligand: a promising approach to kill resistant cancer cells?

Authors:  Guillaume Jacquemin; Sarah Shirley; Olivier Micheau
Journal:  Cell Mol Life Sci       Date:  2010-05-29       Impact factor: 9.261

3.  Targeting of survivin by nanoliposomal ceramide induces complete remission in a rat model of NK-LGL leukemia.

Authors:  Xin Liu; Lindsay Ryland; Jun Yang; Aijun Liao; Cesar Aliaga; Rebecca Watts; Su-Fern Tan; James Kaiser; Sriram S Shanmugavelandy; Andrew Rogers; Kathleen Loughran; Bailey Petersen; Jonathan Yuen; Fanxue Meng; Kendall Thomas Baab; Nancy Ruth Jarbadan; Kathleen Broeg; Ranran Zhang; Jason Liao; Thomas Joseph Sayers; Mark Kester; Thomas P Loughran
Journal:  Blood       Date:  2010-07-29       Impact factor: 22.113

4.  Anticancer activity of total flavonoids isolated from Xianhe Yanling Recipe (仙鹤延龄方).

Authors:  Pei-xun Liu; Jing Gao; Yu-jie Chen; Wei Long; Xiu Shen; Wei-sheng Tang
Journal:  Chin J Integr Med       Date:  2011-06-10       Impact factor: 1.978

Review 5.  TNF-related apoptosis-inducing ligand (TRAIL): a new path to anti-cancer therapies.

Authors:  Peter A Holoch; Thomas S Griffith
Journal:  Eur J Pharmacol       Date:  2009-10-18       Impact factor: 4.432

6.  Quercetin sensitizes fluconazole-resistant candida albicans to induce apoptotic cell death by modulating quorum sensing.

Authors:  B N Singh; D K Upreti; B R Singh; G Pandey; S Verma; S Roy; A H Naqvi; A K S Rawat
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

7.  Quercetin induced apoptosis in association with death receptors and fludarabine in cells isolated from chronic lymphocytic leukaemia patients.

Authors:  M Russo; C Spagnuolo; S Volpe; A Mupo; I Tedesco; G-L Russo
Journal:  Br J Cancer       Date:  2010-07-20       Impact factor: 7.640

Review 8.  TRAIL gene therapy: from preclinical development to clinical application.

Authors:  Thomas S Griffith; Brittany Stokes; Tamara A Kucaba; James K Earel; Rebecca L VanOosten; Erik L Brincks; Lyse A Norian
Journal:  Curr Gene Ther       Date:  2009-02       Impact factor: 4.391

9.  Quercetin enhances TRAIL-induced apoptosis in prostate cancer cells via increased protein stability of death receptor 5.

Authors:  Young-Hwa Jung; Jeonghoon Heo; Yong J Lee; Taeg Kyu Kwon; Young-Ho Kim
Journal:  Life Sci       Date:  2010-01-21       Impact factor: 5.037

10.  Activation of ERK signaling and induction of colon cancer cell death by piperlongumine.

Authors:  H Randhawa; K Kibble; H Zeng; M P Moyer; K M Reindl
Journal:  Toxicol In Vitro       Date:  2013-04-18       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.